Teleflex Acquisition of Nostix, LLC Expands Catheter Tip Placement Solutions
January 11 2016 - 6:45AM
Business Wire
Acquisition Compliments Teleflex’s Existing
ARROW Vascular Positioning System (VPS) to now include familiar
ECG-only technology for the elimination of chest X-ray.
Additionally, an alternative system with
novel navigation capability is under development.
Teleflex Incorporated (NYSE:TFX), a leading global provider of
medical devices for critical care and surgery, has acquired
privately held Nostix, LLC, a Boulder, Colorado developer of
innovative tip confirmation systems that are used to increase the
accuracy of vascular access device placement. Currently, Nostix’s
ECG-only system is being marketed in the United States for use in
placement of peripherally inserted central catheters (PICC) and is
used as an alternative to X-ray confirmation in adult patients.
“Adding the Nostix product line provides our customers with the
ability to implement catheter tip placement solutions that meet
their specific therapeutic and budget needs,” said Benson Smith,
Chairman, President and CEO of Teleflex. “The ECG-only product and
the range of navigation technologies that are under development
will complement our ARROW VPS G4 system by diversifying and
strengthening our PICC tip confirmation and navigation portfolio
and enhance our ability to meet customer needs globally.
Strategically, the addition of this technology will support
Teleflex’s future expansion into tip confirmation for central
venous catheters, chronic hemodialysis catheters and ports. We also
gain access to an innovative product development pipeline, which
includes integrated ultrasound capabilities that will extend our
ability to offer differentiated catheter tip positioning solutions
well into the future.”
The financial terms of the transaction were not disclosed.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit www.teleflex.com.
Teleflex is the home of ARROW®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rüsch® and Weck® – trusted brands united by a common
sense of purpose.
About Nostix, LLC
Nostix, LLC is a privately held medical technology company that
develops and commercializes differentiated PICC tip placement
confirmation and navigation products. It was founded in 2001 and is
headquartered in Boulder, Colorado.
JMP Securities LLC served as exclusive financial advisor to
Nostix in the transaction.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, ARROW, Deknatel, Hudson RCI, LMA,
Pilling, Rüsch and Weck are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates, in the U.S. and/or other
countries.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160111005026/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024